- Filed
- Dec 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Dec 8, 2025 | 17.93M sh |
| Shares Diluted | Q1 2026 · Oct 31, 2025 | 16.28M sh |
| Shares Diluted | Q1 2026 · Oct 31, 2024 | 11.99M sh |
| Operating Cash Flow | Q1 2026 · Oct 31, 2025 | −$90 |
| Operating Cash Flow | Q1 2026 · Oct 31, 2024 | −$159.6K |
| Stockholders Equity | Q1 2026 · Oct 31, 2025 | −$27.67K |
| Stockholders Equity | Q1 2026 · Jul 31, 2025 | $4.47K |
| Stockholders Equity restated | Q1 2026 · Oct 31, 2024 | $1.09M |
| Stockholders Equity restated | Q1 2026 · Jul 31, 2024 | $1.16M |
| Current Liabilities | Q1 2026 · Oct 31, 2025 | $53.5K |
| Current Liabilities | Q1 2026 · Jul 31, 2025 | $38.34K |
| Total Liabilities | Q1 2026 · Oct 31, 2025 | $403.5K |
| Total Liabilities | Q1 2026 · Jul 31, 2025 | $38.34K |
| Current Assets | Q1 2026 · Oct 31, 2025 | $25.83K |
| Current Assets | Q1 2026 · Jul 31, 2025 | $42.81K |
| Total Assets | Q1 2026 · Oct 31, 2025 | $375.83K |
| Total Assets | Q1 2026 · Jul 31, 2025 | $42.81K |
| Eps Diluted | Q1 2026 · Oct 31, 2025 | $0.00 |
| Eps Diluted | Q1 2026 · Oct 31, 2024 | −$0.01 |
| Sga Expense | Q1 2026 · Oct 31, 2025 | $1.59K |
| Sga Expense restated | Q1 2026 · Oct 31, 2024 | $90 |
| Net Income | Q1 2026 · Oct 31, 2025 | −$32.14K |
| Net Income restated | Q1 2026 · Oct 31, 2024 | −$74.49K |
| Operating Income | Q1 2026 · Oct 31, 2025 | −$32.14K |
| Operating Income restated | Q1 2026 · Oct 31, 2024 | −$37.82K |
| Revenue | Q1 2026 · Oct 31, 2025 | $0 |
| Revenue restated | Q1 2026 · Oct 31, 2024 | $0 |